https://youtu.be/4rB2G3iK3UE Key highlights from Shilpa Medicare Ltd (SHILPAMED) Q1 FY23 Earnings Concall Q&A Highlights: Vineet Gala of Monarch Networth asked about the
Shilpa Medicare Ltd Q1 FY23 Earnings Conference Call Insights
Categories
pharmaceuticals
Marksans Pharma Limited Q1 FY23 Earnings Conference Call Insights
https://youtu.be/9PAJ7vTTG5E Key highlights from Marksans Pharma Limited (MARKSANS) Q1 FY23 Earnings Concall Management Update: MARKSANS said it aims to increase its R&D
Supriya Lifescience Ltd Q1 FY23 Earnings Conference Call Insights
https://youtu.be/LNBcyeiXX0U Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q1 FY23 Earnings Concall Management Update: SUPRIYA said the company is extending its backward
Balaxi Pharmaceuticals Ltd (BALAXI) Q1 FY23 Earnings Concall Transcript
Balaxi Pharmaceuticals Ltd (NSE:BALAXI) Q1 FY23 Earnings Concall dated Aug. 18, 2022 Corporate Participants: Ashish Maheshwari -- Managing Director Pranav Maheshwari --
SMS Pharmaceuticals Limited (SMSPHARMA) Q2 FY23 Earnings Concall Transcript
SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Q2 FY23 Earnings Concall Aug. 18, 2022 Corporate Participants: P. Vamsi Krishna -- Executed Director LakshminarayanaTammineedi -- Chief
Aurobindo Pharma Limited Q1 FY 2023 Research Tear Sheet
Stock Data Ticker: AUROPHARMA Exchange :NSE and BSE Industry: Automobile Price Performance Last 7 days 4.36% YTD -19.19% Last 12 months -28.17%
Divi’s Laboratories Ltd Q1 FY23 Earnings Conference Call Insights
https://youtu.be/EPaxfKgyoZQ Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q1 FY23 Earnings Concall Q&A Highlights: Tushar Manudhane from Motilal Oswal asked about the
Aarti Industries Ltd Q1 FY23 Earnings Conference Call Insights
https://youtu.be/CUmhEBZpLC0 Key highlights from Aarti Industries Ltd (AARTIIND) Q1 FY23 Earnings Concall Management Update: [00:05:18] AARTIIND said it has started seeing volume
Aarti Industries reported stellar performance in Q1FY23, Revenue up by 45%
On Wednesday, Aarti Industry reported its earnings for the quarter ended June 30, 2022. The revenue from operations (gross) grew by 45%
Glenmark Life Sciences Limited Q1 FY23 Earnings Conference Call Insights
https://youtu.be/02Igs_HUAfo Key highlights from Glenmark Life Sciences Limited (GLS) Q1 FY23 Earnings Concall Q&A Highlights: [00:14:56] Neha Manpuria from Bank of America
JB Chemicals & Pharmaceuticals Limited Q1 FY23 Earnings Conference Call Insights
Key highlights from JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q1 FY23 Earnings Concall Q&A Highlights: Rahul Jeewani from IIFL Securities asked about
CAPLIN POINT LABORATORIES LTD (CAPPL) Q2 FY22 Earnings Concall Transcript
CAPLIN POINT LABORATORIES LTD (NSE:CAPPL) Q2 FY22 Earnings Concall dated Aug. 05, 2022 Corporate Participants: Vivek Paarthipan -- Chief Operating Officer M.
Lupin Ltd (LUPIN) Q1 FY23 Earnings Concall Transcript
Lupin Ltd (NSE: LUPIN) Q1 FY23 Earnings Concall dated Aug. 04, 2022 Corporate Participants: Kamal Kishore Sharma -- Vice Chairman of the
Earnings Infographic: Dr. Lal PathLabs Q1 2023 revenue and profit decline
Dr. Lal PathLabs Ltd (NSE: LALPATHLAB), a leading provider of diagnostic and related healthcare services, has reported lower revenues and earnings for
Piramal Enterprises Ltd Q1 FY23 Earnings Conference Call Insights
https://youtu.be/kHUXId_eoxg Key highlights from Piramal Enterprises Ltd (PEL) Q1 FY23 Earnings Concall Management Update: PEL said that it’s on track to completion
Torrent Pharmaceuticals Ltd Q1 FY23 Earnings Conference Call Insights
Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q1 FY23 Earnings Concall Management Update: TORNTPHARM launched four products in 1Q23 and will be
Sun Pharmaceutical Industries Ltd Q1 FY23 Earnings Conference Call Insights
Key highlights from Sun Pharmaceutical Industries Ltd (SUNPHARMA) Q1 FY23 Earnings Concall Management Update: SUNPHARMA recorded the highest ever quarterly revenue in
Infographic: Torrent Pharma opens this year with moderate performance as net Profit soars by 7%
On Friday, Torrent Pharma reported a 7.2 percent increase in its consolidated net profit to Rs 354 crore for the June 2022
Sun Pharmaceutical Industries Ltd (SUNPHARMA) Q1 FY23 Earnings Concall Transcript
Sun Pharmaceutical Industries Ltd (NSE:SUNPHARMA) Q1 FY23 Earnings Concall dated Jul. 29, 2022 Corporate Participants: Nimish Desai -- Investor Relations Dilip Shanghvi
Torrent Pharmaceuticals Ltd (TORNTPHARM) Q1 FY22 Earnings Concall Transcript
Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) Q1 FY22 Earnings Concall dated Jul. 29, 2022 Corporate Participants: Sudhir Menon -- Executive Director, Finance and Chief
Dr. Reddy’s Laboratories (DRREDDY) Q1 FY23 Earnings Concall Transcript
Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 FY23 Earnings Concall dated Jul. 28, 2022 Corporate Participants: Amit Agarwal -- Head of Investor Relations and